The PBK inhibitor OTS964/OTS514 was shown to inhibit cytokinesis and cancer cell growth (Matsuo et al., 2014), and OTS964/OTS514 induced the apoptosis of lung cancer cells including small cell lung cancer (SCLC) cells (Park et al., 2017). Here, PBK is linked to small cell lung carcinoma.